Selcia: Contract Research Services for the Life Sciences Industry

Selcia Radiolabelling

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions. Read more

Medicinal Chemistry
Assay Development and Screening
Target Class and Disease Expertise


Selcia Radiolabelling

The leader in providing high quality 14C radiolabelled compounds for your essential studies.
Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
GLP Analytics



08 January 2015

Selcia scientists have determined the absolute stereochemistry of the structure of teixobactin, a novel antibacterial macrocyclic peptide whose discovery is described in a recent article published in the journal Nature by NovoBiotic Pharmaceuticals. 

03 February 2014

An initiative is under way to develop new drugs for a devastating tropical disease that threatens almost 70 million people in Africa.

25 November 2013

Selcia Limited, the international life sciences CRO, has announced a successful inspection of its GMP radiochemistry facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).


  • 23 March 2015 to 25 March 2015
    Selcia is attending the Society of Toxicology's Annual Meeting and ToxExpo in San Diego, USA.